These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14039841)

  • 21. Chloramphenicol-sensitive and-insensitive phases of the lethal action of streptomycin.
    HURWITZ C; ROSANO CL
    J Bacteriol; 1962 Jun; 83(6):1202-9. PubMed ID: 14450180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of a chloramphenicol-insensitive phase of streptomycin action.
    PLOTZ PH; DAVIS BD
    J Bacteriol; 1962 Apr; 83(4):802-5. PubMed ID: 14038403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver enzymes in para-aminosalicylate-induced injury and the effect of thyroxine administration.
    KRISHNAN PS; MEHROTRA RM; SAXENA YR
    J Pathol Bacteriol; 1962 Jan; 83():21-30. PubMed ID: 14459702
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of chloramphenicol on phage adsorption.
    ROSENTHAL HA
    Acta Virol; 1962 Sep; 6():471-3. PubMed ID: 14038772
    [No Abstract]   [Full Text] [Related]  

  • 25. EMERGENCE OF ANTIBIOTIC-RESISTANT ESCHERICHIA COLI IN A CLOSED-POPULATION WHEN CHLORAMPHENICOL WAS USED EXTENSIVELY.
    DEVETSKI R; TILLMAN P; NORSEN J; LEPPER M
    Antimicrob Agents Chemother (Bethesda); 1963; 161():714-20. PubMed ID: 14274990
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance of E. coli to chloramphenicol and substances of similiar structure].
    SANTARATO R
    Riv Ist Sieroter Ital; 1953; 28(1):48-54. PubMed ID: 13075778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental thrombocytosis induced by PAS].
    GABOR M; PIUKOVICH I; BARDOCZY A; SZABO L
    Arch Int Pharmacodyn Ther; 1961 Feb; 130():195-9. PubMed ID: 13702792
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of a chloramphenicol efflux system in Escherichia coli isolated from poultry carcass.
    Moreira MA; Oliveira JA; Teixeira LM; Moraes CA
    Vet Microbiol; 2005 Aug; 109(1-2):75-81. PubMed ID: 15963664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of 58 titrations of sensitivity to streptomycin, PAS and isoniazid of Mycobacterium tuberculosis].
    BURDIN JC; SCHMITT J; de LAVERGNE ; BRIQUEL P; RIBAR D
    Rev Med Nancy; 1960 Feb; 85():131-5. PubMed ID: 13806020
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical and experimental bases of PAS therapy].
    LEHMANN J
    Wien Med Wochenschr; 1961 Nov; 111():803-5. PubMed ID: 14463769
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of PAS loading on the secretion relationships of the stomach].
    CSERGO I; BIKICH G; HEVER O; BORSAY J
    Tuberkulosearzt; 1960 Jan; 14():16-22. PubMed ID: 13813152
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of coresistance in the development of resistance to chloramphenicol in Escherichia coli isolated from sick cattle and pigs.
    Harada K; Asai T; Kojima A; Ishihara K; Takahashi T
    Am J Vet Res; 2006 Feb; 67(2):230-5. PubMed ID: 16454626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on chloramphenicol inactivation by microorganisms. 2. Relation between chloramphenicol inactivation and chloramphenicol resistance in various microorganisms].
    MIYAMURA S; OKETANI S
    Nihon Saikingaku Zasshi; 1962 Apr; 17():294-6. PubMed ID: 14474821
    [No Abstract]   [Full Text] [Related]  

  • 34. A multiple-antibiotic resistance-independent active chloramphenicol efflux in an Escherichia coli clinical isolate.
    Bellaaj A; Mallea M; Bollet C; Belhadj C; Belhadj O; Ben-Mahrez K
    Drugs Exp Clin Res; 2002; 28(2-3):99-104. PubMed ID: 12224384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chloramphenicol sensitivity of monocytogenetic cultures of E. coli and S. aureus].
    SANTARATO R
    Riv Ist Sieroter Ital; 1953; 28(2):107-12. PubMed ID: 13075786
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 1: An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM) and para-aminosalicylic acid (PAS)].
    FUKUI A
    Kekkaku; 1959 Nov; 34():793-6. PubMed ID: 13825599
    [No Abstract]   [Full Text] [Related]  

  • 37. [Practical observations on the treatment of brucellosis with PAS and chloramphenicol].
    MOLIN P
    Rass Medica; 1951 Jan; 28(1):12-4. PubMed ID: 14816594
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 2. An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM), isonicotinic acid hydrazide (INH) and/or para-aminosalicylic acid (PAS)].
    FUKUI A
    Kekkaku; 1959 Dec; 34():851-6. PubMed ID: 13825600
    [No Abstract]   [Full Text] [Related]  

  • 39. [Apropos of resistance of Koch's bacillus to streptomycin, para-aminosalicylic acid, isonicotinoyl hydrazide and viomycin. Resistance of the organisms at the time of admission of the patient to the sanatorium].
    COX D
    Acta Tuberc Pneumol Belg; 1961; 52():206-13. PubMed ID: 13881889
    [No Abstract]   [Full Text] [Related]  

  • 40. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
    Nagachar N; Ratledge C
    FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.